Reproducibility of Transcranial Doppler ultrasound in the middle cerebral artery
- PMID: 30200977
- PMCID: PMC6131943
- DOI: 10.1186/s12947-018-0133-z
Reproducibility of Transcranial Doppler ultrasound in the middle cerebral artery
Abstract
Background: Transcranial Doppler ultrasound remains the only imaging modality that is capable of real-time measurements of blood flow velocity and microembolic signals in the cerebral circulation. We here assessed the repeatability and reproducibility of transcranial Doppler ultrasound in healthy volunteers and patients with symptomatic carotid artery stenosis.
Methods: Between March and August 2017, we recruited 20 healthy volunteers and 20 patients with symptomatic carotid artery stenosis. In a quiet temperature-controlled room, two 1-h transcranial Doppler measurements of blood flow velocities and microembolic signals were performed sequentially on the same day (within-day repeatability) and a third 7-14 days later (between-day reproducibility). Levels of agreement were assessed by interclass correlation co-efficient.
Results: In healthy volunteers (31±9 years, 11 male), within-day repeatability of Doppler measurements were 0.880 (95% CI 0.726-0.950) for peak velocity, 0.867 (95% CI 0.700-0.945) for mean velocity, and 0.887 (95% CI 0.741-0.953) for end-diastolic velocity. Between-day reproducibility was similar but lower: 0.777 (95% CI 0.526-0.905), 0.795 (95% CI 0.558-0.913), and 0.674 (95% CI 0.349-0.856) respectively. In patients (72±11 years, 11 male), within-day repeatability of Doppler measurements were higher: 0.926 (95% CI 0.826-0.970) for peak velocity, 0.922 (95% CI 0.817-0.968) for mean velocity, and 0.868 (95% CI 0.701-0.945) for end-diastolic velocity. Similarly, between-day reproducibility revealed lower values: 0.800 (95% CI 0.567-0.915), 0.786 (95% CI 0.542-0.909), and 0.778 (95% CI 0.527-0.905) respectively. In both cohorts, the intra-observer Bland Altman analysis demonstrated acceptable mean measurement differences and limits of agreement between series of middle cerebral artery velocity measurements with very few outliers. In patients, the carotid stenoses were 30-40% (n = 9), 40-50% (n = 6), 50-70% (n = 3) and > 70% (n = 2). No spontaneous embolisation was detected in either of the groups.
Conclusions: Transcranial Doppler generates reproducible data regarding the middle cerebral artery velocities. However, larger studies are needed to validate its clinical applicability.
Trial registration: ClinicalTrial.gov (ID NCT 03050567), retrospectively registered on 15/05/2017.
Trial registration: ClinicalTrials.gov NCT03050567.
Keywords: Carotid artery stenosis; Ischaemic stroke; Microembolic signals; Transcranial Doppler.
Conflict of interest statement
Authors’ information
JK: Clinical Research Fellow presently supported by the British Heart Foundation Clinical Research Fellowship (FS/17/50/33061). RH: Medical student at University of Edinburgh. KS: Vascular technologist specialised in the transcranial Doppler imaging at Queen Elizabeth University Hospital in Glasgow. MW: Professor of Clinical Pharmacology, Head of the Undergraduate Medical School University of Glasgow and Director of Scottish Stroke Research Network. WW: MRC Clinician Scientist & Honorary Consultant Neurologist at Royal Infirmary of Edinburgh. JW: Head of Edinburgh Imaging, Director of Brain Research Imaging Centre, Honorary Consultant Neuroradiologist at Royal Infirmary of Edinburgh. DEN: British Heart Foundation John Wheatley Chair of Cardiology, Consultant Cardiologist at Royal Infirmary of Edinburgh.
Ethics approval and consent to participate
Ethical approval was granted by the South East Scotland Research Ethics Committee 01 (approval number 16/SS/0217), and written consent was obtained from all participants.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests to declare.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures





Similar articles
-
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.Lancet Neurol. 2010 May;9(5):489-97. doi: 10.1016/S1474-4422(10)70060-0. Epub 2010 Mar 22. Lancet Neurol. 2010. PMID: 20335070 Clinical Trial.
-
Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease.Stroke. 2003 Apr;34(4):945-9. doi: 10.1161/01.STR.0000062351.66804.1C. Epub 2003 Mar 6. Stroke. 2003. PMID: 12624217
-
Cognitive Impairment Correlates Linearly with Mean Flow Velocity by Transcranial Doppler below a Definable Threshold.Cerebrovasc Dis Extra. 2020;10(1):21-27. doi: 10.1159/000506924. Epub 2020 Apr 14. Cerebrovasc Dis Extra. 2020. PMID: 32289771 Free PMC article.
-
Assessment of blood flow velocity and diameter of the middle cerebral artery during the acetazolamide provocation test by use of transcranial Doppler sonography and MR imaging.AJNR Am J Neuroradiol. 2000 Aug;21(7):1207-11. AJNR Am J Neuroradiol. 2000. PMID: 10954270 Free PMC article.
-
Transcranial Doppler ultrasonography in intensive care.Eur J Anaesthesiol Suppl. 2008;42:167-73. doi: 10.1017/S0265021507003341. Eur J Anaesthesiol Suppl. 2008. PMID: 18289437 Review.
Cited by
-
Comparison of transcranial doppler ultrasound indices in large and small vessel disease cerebral infarction.Curr J Neurol. 2021 Oct 7;20(4):229-234. doi: 10.18502/cjn.v20i4.8349. Curr J Neurol. 2021. PMID: 38011485 Free PMC article.
-
Reproducibility and diurnal variation in middle cerebral artery blood velocity in healthy humans.Exp Physiol. 2023 May;108(5):692-705. doi: 10.1113/EP090873. Epub 2023 Mar 23. Exp Physiol. 2023. PMID: 36951536 Free PMC article.
-
Cerebral vasoreactivity, a surrogate marker of cerebrovascular disease, is not impaired in subjects with lifetime, untreated, congenital isolated GH deficiency.Endocrine. 2020 Nov;70(2):388-395. doi: 10.1007/s12020-020-02415-0. Epub 2020 Jul 12. Endocrine. 2020. PMID: 32656695
-
Safety and efficacy of a novel robotic transcranial doppler system in subarachnoid hemorrhage.Sci Rep. 2022 Feb 10;12(1):2266. doi: 10.1038/s41598-021-04751-1. Sci Rep. 2022. PMID: 35145104 Free PMC article.
-
Surface Point Cloud Ultrasound with Transcranial Doppler: Coregistration of Surface Point Cloud Ultrasound with Magnetic Resonance Angiography for Improved Reproducibility, Visualization, and Navigation in Transcranial Doppler Ultrasound.J Digit Imaging. 2020 Aug;33(4):930-936. doi: 10.1007/s10278-020-00328-y. J Digit Imaging. 2020. PMID: 32076925 Free PMC article.
References
-
- Writing G, Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, Halliday A, Hamilton G, Kakisis J, Kakkos S, Lepidi S, Markus HS, McCabe DJ, Roy J, Sillesen H, van den Berg JC, Vermassen F, Esvs Guidelines C, Kolh P, Chakfe N, Hinchliffe RJ, Koncar I, Lindholt JS, Vega de Ceniga M, Verzini F, Esvs Guideline R, Archie J, Bellmunt S, Chaudhuri A, Koelemay M, et al. Editor's Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS) Eur J Vasc Endovasc Surg. 2018;55:3–81. doi: 10.1016/j.ejvs.2017.06.021. - DOI - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical